A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency

NCT03378531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Arginase I Deficiency
Hyperargininemia

Interventions

DRUG: AEB1102

Sponsor

Aeglea Biotherapeutics